Centessa Pharmaceuticals (CNTA) EBITDA (2020 - 2026)
Centessa Pharmaceuticals (CNTA) reported EBITDA of -$80.5 million for Q1 2026, down 184.89% year-over-year from $94.9 million in Q1 2025, and down 21.95% quarter-over-quarter from -$66.0 million in Q4 2025.
Centessa Pharmaceuticals (CNTA) EBITDA (2020 - 2026) Analysis & Trends
Centessa Pharmaceuticals (CNTA) has 7 years of EBITDA data on file, last reported at -$80.5 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$80.5 million, down 184.89% year-over-year; the trailing twelve-month figure through Mar 2026 was -$251.3 million (down 12.49% YoY), and the FY2025 annual result was -$199.0 million, up 14.59% from the prior year.
- EBITDA fell to -$80.5 million in Q1 2026 per CNTA's latest filing, from -$66.0 million in the prior quarter.
- Over five years, EBITDA peaked at -$23.3 million in Q2 2023 and troughed at -$109.2 million in Q4 2024.
- A 5-year average of -$51.7 million and a median of -$49.8 million in 2023 frame the typical range for EBITDA.
- The sharpest annual moves came in 2022 and 2024: EBITDA surged 76.65% in 2022, then plunged 202.33% in 2024.
- A 5-year view of EBITDA shows it stood at -$43.0 million in 2022, then climbed by 15.94% to -$36.1 million in 2023, then sank by 202.33% to -$109.2 million in 2024, then soared by 39.52% to -$66.0 million in 2025, then decreased by 21.95% to -$80.5 million in 2026.
- Business Quant data shows CNTA's EBITDA at -$80.5 million in Q1 2026, -$66.0 million in Q4 2025, and -$53.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.44 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -65.83 Mn |
| 10 | Centessa Pharmaceuticals | 6.10 Bn | 6.10 Bn | - | -80.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80.55 Mn |
| Dec 31, 2025 | -66.05 Mn |
| Sep 30, 2025 | -53.88 Mn |
| Jun 30, 2025 | -50.83 Mn |
| Mar 31, 2025 | -28.27 Mn |
| Dec 31, 2024 | -109.21 Mn |
| Sep 30, 2024 | -42.07 Mn |
| Jun 30, 2024 | -43.84 Mn |
| Mar 31, 2024 | -37.92 Mn |
| Dec 31, 2023 | -36.12 Mn |
| Sep 30, 2023 | -38.82 Mn |
| Jun 30, 2023 | -23.34 Mn |
| Mar 31, 2023 | -49.82 Mn |
| Dec 31, 2022 | -42.98 Mn |
| Sep 30, 2022 | -54.43 Mn |
| Jun 30, 2022 | -65.79 Mn |
| Mar 31, 2022 | -55.20 Mn |
| Dec 31, 2021 | -62.82 Mn |
| Sep 30, 2021 | -40.64 Mn |
| Jun 30, 2021 | -40.36 Mn |